Home Newsfeeds UBS Maintains Sell on Bed Bath & Beyond, Lowers Price Target to $1.5

UBS Maintains Sell on Bed Bath & Beyond, Lowers Price Target to $1.5

UBS analyst Michael Lasser maintains Bed Bath & Beyond (NASDAQ:BBBY) with a Sell and lowers the price target from $3.5 to $1.5.

byBenzinga Newsdesk

January 6, 2023

1 minute read

UBS analyst Michael Lasser maintains Bed Bath & Beyond (NASDAQ:BBBY) with a Sell and lowers the price target from $3.5 to $1.5.

Why Bill.com Stock Is Falling 20% Friday

By Henry Khederian

February 3, 11:55 AM

Bill.com Holdings Inc (NASDAQ: BILL) shares are trading lower by 21.72% to $100.91 Friday morning after the company reported second-quarter earnings result

BILL

Investor Optimism Decreases Slightly; Inflation Data In Focus

By Avi Kapoor

April 10, 1:50 AM

The CNN Money Fear and Greed index showed some decline in the overall market sentiment, while the index remained in the "Greed" zone on Tuesday. U.S. stocks closed mixed on Tuesday, with the Dow Jones index settling slightly lower during the session.

CGNT

Bizarre: Indian Couple Sells Infant To Get iPhone And Instagram Stardom

By Shomik Sen Bhattacharjee

July 28, 8:40 AM

This story was first published on the Benzinga India portal.

AAPL

Adverum Biotechnologies Cuts Workforce, Prioritizes ADVM-022

By Vandana Singh

July 7, 8:02 AM

Adverum Biotechnologies Inc (NASDAQ:ADVM) announced a restructuring plan, including reductions in headcount and expenses, to prioritize its clinical development of…

ADVM

UBS Maintains Sell on Bed Bath & Beyond, Lowers Price Target to $1.5

Related Posts

Why Bill.com Stock Is Falling 20% Friday

Investor Optimism Decreases Slightly; Inflation Data In Focus

Bizarre: Indian Couple Sells Infant To Get iPhone And Instagram Stardom

Adverum Biotechnologies Cuts Workforce, Prioritizes ADVM-022